Skip to content

13G/A filed by BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND L P and 9 other reporting persons reported 8,278,164 ANNX shares, 4.4% of the class, as of 2026-09-30, in a 13G/A accepted by EDGAR 2026-11-16 21:05:44 UTC.

Accession
0000921895-26-003167
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Stake

Shares
8,278,164
Percent of class
4.4%
Event date
2026-09-30

How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.

Read for the filer group BVF INC/IL.

Reporting persons

PersonTypeSole votingShared votingSole dispositiveShared dispositiveAggregatePercent
BIOTECHNOLOGY VALUE FUND L PPN04,357,86604,357,8664,357,8662.3%
BVF I GP LLCOO04,357,86604,357,8664,357,8662.3%
BIOTECHNOLOGY VALUE FUND II LPPN03,266,79803,266,7983,266,7981.7%
BVF II GP LLCOO03,266,79803,266,7983,266,7981.7%
Biotechnology Value Trading Fund OS LPPN0522,9060522,906522,9060.3%
BVF Partners OS Ltd.CO0522,9060522,906522,9060.3%
BVF GP HOLDINGS LLCOO07,624,66407,624,6647,624,6644%
BVF PARTNERS L P/ILIA,PN08,278,16408,278,1648,278,1644.4%
BVF INC/ILCO08,278,16408,278,1648,278,1644.4%
LAMPERT MARK NIN08,278,16408,278,1648,278,1644.4%